Day: August 16, 2021

PETAH-TIKVA, Israel, Aug. 16, 2021 (GLOBE NEWSWIRE) — Global-e Online Ltd. (Nasdaq: GLBE) the company that makes global e-commerce border agnostic, today reported financial results for the second quarter of 2021 as well as outlook for the third quarter and full year 2021 “The record results we are publishing today for the second quarter of 2021, together with the updated guidance for the third quarter and full year, illustrate the continued momentum of our business, as evident from both Gross Merchandise Value (GMV) and revenues growing more than 90% year over year, improved profitability and several key clients we launched with this quarter”, said Amir Schlachet, Founder and CEO of Global-e. “In parallel, we remain focused on executing across all our strategic vectors, from geographical expansion, to adding additional features...

Added Additional Treatment Arm and Provided Enrollment Update for Ongoing ELX-02 Phase 2 Clinical Trials for Cystic Fibrosis (CF) Nominated ZKN-013 as Lead Candidate for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and Junctional Epidermolysis Bullosa (JEB) Programs Advanced Multiple Preclinical Rare Inherited and Targeted Oncology Programs Received Funding Award from Cystic Fibrosis Foundation to Develop Ribosome Modulating Agents (RMAs) with TURBO-ZM™ Platform Raised Approximately $52M in Gross Proceeds Through Public Offering WATERTOWN, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today reported its financial results for the three months ended June 30, 2021, and provided a business update. “Since the acquisition...

Reports Top Line Year Over Year Quarterly Revenue Growth of 131% SANTA ANA, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) — Unrivaled Brands, Inc. (OTCQX: UNRV) (“Unrivaled” or the “Company”), a multi-state vertically integrated company focused on the cannabis sector with operations in California, Oregon, and Nevada, today reported its financial results for the quarter ended June 30, 2021. Frank Knuettel, Chief Executive Officer of Unrivaled Brands stated, “On the operations side, we have continued to make improvements and see gains in our existing operations. With revenues of $6.3 million in the second quarter of 2021, we recorded our largest quarter of revenues since the fourth quarter of 2019, registering quarterly revenue growth of approximately 131% compared to the same period of 2020. “As part of this revenue...

Net Sales Increased 71.8% Year Over Year to $7.4 MillionGross Profit Increased 148.3% Year Over Year to $3.6 Million PLANO, Texas, Aug. 16, 2021 (GLOBE NEWSWIRE) — Stryve Foods, Inc. (“Stryve” or “the Company”), (NASDAQ: SNAX), an emerging healthy snack and eating platform disrupting traditional CPG categories, and a leader in the air-dried meat snack industry in the United States, today announced results for the second quarter ended June 30, 2021 and provided a business update. Financial Highlights for the Second Quarter 2021 Versus the Prior Year PeriodNet sales increased to $7.4 million, representing 71.8% growth. Gross profit increased to $3.6 million, representing 148.3% growth. Gross margin increased to 48.7% compared to a gross margin of 33.7% in the prior year period. Strong wholesale gains contributing 45.6% of net sales,...

Significantly Increasing Revenue Opportunities with Planned Launch of First OTC Product, Expanded Distribution and Additional Applications for Regulatory Approval and Medicare Reimbursement ELMSFORD, N.Y., Aug. 16, 2021 (GLOBE NEWSWIRE) — NanoVibronix, Inc., (NASDAQ: NAOV), a healthcare device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today reported its financial results for the quarter ended June 30, 2021 and provided a business update. Financial and Business HighlightsRevenue increased 18% to $318,000, which included the first shipment of products to Ultra Pain Products, Inc. (UPPI) under its amended contract which extended terms and increased minimum purchase requirements to $8 million over three years Launched OTC pain management device, PainShield...

Company Delivers 14% Sequential Net Revenue Growth in Second Quarter 2021 Operating Expenses Decline $0.7 Million or 15% in Second Quarter 2021 Company Prepares for Official MP Performance Energy Launch in August 2021 and Expects Energy Business including FitMiss Energy Product to Deliver $30 million of Annual Sales in 2023 LAS VEGAS, Aug. 16, 2021 (GLOBE NEWSWIRE) — MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today reported financial results for the second quarter ended June 30, 2021. Mr. Ryan Drexler, the Chairman of the Board of Directors and Chief Executive Officer, stated, “I’m encouraged despite the headwinds affecting our industry, we were able to finish the second quarter with a 14% increase in net revenue over the first quarter...

NOT FOR RELEASE OR DISSEMINATION INTO THE UNITED STATES Q2 2021 Financial Highlights(1):Revenues increased 83.3% to $756.8 million Gross Margin at 17.3% Adjusted EBITDA(3) amounted to $94.0 million Net Earnings amounted to $53.1 million Quarterly dividend of $0.12 per share paid on July 15, 2021(4)VANCOUVER, British Columbia, Aug. 16, 2021 (GLOBE NEWSWIRE) — Doman Building Materials Group Ltd. (“Doman” or “the Company”) (TSX:DBM; DBM.NT.A) announced today its second quarter 2021 financial results(1) for the period ended June 30, 2021. For the three-month period ended June 30, 2021(1), consolidated revenues increased by 83.3% to $756.8 million when compared to $412.9 million in the same period in 2020. The increase in revenues was partially comprised of the results from acquisitions, with the balance of the increase attributable...